Michał Kunc (Michal Kunc)

Scopus Author ID ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Venues

Biomedicines

Diagnostics (Basel, Switzerland)

Cancers

Head and neck pathology

Medical University of Gdańsk

Medical University of Gdańsk (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Gdańsk Oct 01 2017

Poland

PhD candidate :: Department of Pathomorphology

Education History

Medical University of Gdańsk Oct 01 2010 - Jun 30 2016

Poland

PHD :: Department of Pathology

Publications

Aleksandra Ciarka, Michał Piątek, Rafał Pęksa, Michał Kunc, Elżbieta Senkus
Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes. Biomedicines 12 (4) (2024)
Aleksandra Ciarka, Michał Piątek, Rafał Pęksa, Michał Kunc, Elżbieta Senkus
Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes. Biomedicines 12 (4) (2024)
Małgorzata Edyta Wojtyś, Kajetan Kiełbowski, Michał Kunc, Seweryn Adam Skrzyniarz, Piotr Lisowski, Rafał Becht, Paulina Żukowska, Konrad Ptaszyński, Janusz Wójcik
Extremely Rare Pulmonary Metastases of Skin Basal Cell Carcinoma: Report of Two Cases with Clinicopathological Features. Biomedicines 11 (2) (2023)
Małgorzata Edyta Wojtyś, Kajetan Kiełbowski, Michał Kunc, Seweryn Adam Skrzyniarz, Piotr Lisowski, Rafał Becht, Paulina Żukowska, Konrad Ptaszyński, Janusz Wójcik
Extremely Rare Pulmonary Metastases of Skin Basal Cell Carcinoma: Report of Two Cases with Clinicopathological Features. Biomedicines 11 (2) (2023)
Michał Kunc, Natalia Żemierowska, Filip Skowronek, Wojciech Biernat
Diagnostic test accuracy meta-analysis of PRAME in distinguishing primary cutaneous melanomas from benign melanocytic lesions. Histopathology (2023)
Małgorzata Edyta Wojtyś, Kajetan Kiełbowski, Michał Kunc, Seweryn Adam Skrzyniarz, Piotr Lisowski, Rafał Becht, Paulina Żukowska, Konrad Ptaszyński, Janusz Wójcik
Extremely Rare Pulmonary Metastases of Skin Basal Cell Carcinoma: Report of Two Cases with Clinicopathological Features. Biomedicines 11 (2) (2023)
Małgorzata Zdrojewska, Emilia Mech-Siebieszuk, Renata Świątkowska-Stodulska, Bartosz Regent, Michał Kunc, Łukasz Zdrojewski, Krzysztof Sworczak
Adrenal Tumors in Young Adults: Case Reports and Literature Review. Medicina (Kaunas, Lithuania) 58 (6) (2022)
Małgorzata Edyta Wojtyś, Olga Kacalska-Janssen, Konrad Ptaszyński, Piotr Lisowski, Michał Kunc, Janusz Wójcik, Tomasz Grodzki
Benign Metastasizing Leiomyoma of the Lung: Diagnostic Process and Treatment Based on Three Case Reports and a Review of the Literature. Biomedicines 10 (10) (2022)
Rafał Pęksa, Michał Kunc, Piotr Czapiewski, Michał Piątek, Stanisław Hać, Barbara Radecka, Wojciech Biernat
Tumor Budding Is an Independent Prognostic Factor in Pancreatic Adenocarcinoma and It Positively Correlates with PD-L1 Expression on Tumor Cells. Biomedicines 10 (7) (2022)
Małgorzata Anna Krawczyk, Michał Kunc, Małgorzata Styczewska, Anna Gabrych, Gabrielle Karpinsky, Ewa Iżycka-Świeszewska, Ewa Bien
High Expression of Solute Carrier Family 2 Member 1 (SLC2A1) in Cancer Cells Is an Independent Unfavorable Prognostic Factor in Pediatric Malignant Peripheral Nerve Sheath Tumor. Diagnostics (Basel, Switzerland) 11 (4) (2021)
Michał Kunc, Alexandra Kamieniecki, Grzegorz Walczak, Tomasz Nowicki, Bartosz Wasąg, Bogusław Mikaszewski, Dominik Stodulski, Wojciech Biernat
Intrasalivary Thymic Carcinoma: A Case Report and Literature Review. Head and neck pathology (2021)
Michał Kunc, Marta Popęda, Wojciech Biernat, Elżbieta Senkus
Lost but Not Least-Novel Insights into Progesterone Receptor Loss in Estrogen Receptor-Positive Breast Cancer. Cancers 13 (19) (2021)
Łukasz Zapała, Michał Kunc, Sumit Sharma, Wojciech Biernat, Piotr Radziszewski
Low Lymphocyte-to-Monocyte Ratio Is the Potential Indicator of Worse Overall Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus. Diagnostics (Basel, Switzerland) 11 (11) (2021)
Rafał Pęksa, Michał Kunc, Marta Popęda, Michał Piątek, Michał Bieńkowski, Jolanta Żok, Anna Starzyńska, Adrian Perdyan, Marek Sowa, Renata Duchnowska, Wojciech Biernat
Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes. Cancers 13 (8) (2021)
Michał Kunc, Kevin Miszewski, Michał Bieńkowski, Alexandra Kamieniecki, Marcin Ekman, Adam Gorczyński, Wojciech Biernat
Who Is a Pathologist According to Oncology Patients and Internet Users? A Survey Study. Journal of cancer education : the official journal of the American Association for Cancer Education 36 (2) (2021)
Łukasz Zapała, Sumit Sharma, Michał Kunc, Piotr Zapała, Jakub Kłącz, Piotr Korczyński, Michał Lipowski, Michał Późniak, Tomasz Suchojad, Tomasz Drewa, Marcin Matuszewski, Piotr Radziszewski
Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus. Journal of clinical medicine 10 (17) (2021)
Łukasz Jan Adamski, Anna Starzyńska, Paulina Adamska, Michał Kunc, Monika Sakowicz-Burkiewicz, Giulia Marvaso, Daniela Alterio, Aleksandra Korwat, Barbara Alicja Jereczek-Fossa, Rafał Pęksa
High PD-L1 Expression on Tumor Cells Indicates Worse Overall Survival in Advanced Oral Squamous Cell Carcinomas of the Tongue and the Floor of the Mouth but Not in Other Oral Compartments. Biomedicines 9 (9) (2021)
Michał Kunc, Marta Popęda, Magdalena Niemira, Anna Szałkowska, Michał Bieńkowski, Rafał Pęksa, Aleksandra Łacko, Barbara S Radecka, Marcin Braun, Joanna Pikiel, Maria Litwiniuk, Katarzyna Pogoda, Ewa Iżycka-Świeszewska, Adam Jacek Kretowski, Anna J Żaczek, Wojciech Biernat, Elżbieta Senkus
microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study. Diagnostics (Basel, Switzerland) 10 (9) (2020)
Michał Bieńkowski, Michał Kunc, Mariola Iliszko, Alina Kuźniacka, Michał Studniarek, Wojciech Biernat
MAML2 rearrangement as a useful diagnostic marker discriminating between Warthin tumour and Warthin-like mucoepidermoid carcinoma. Virchows Archiv : an international journal of pathology 477 (3) (2020)
Malgorzata Anna Krawczyk, Małgorzata Styczewska, Ewa M Sokolewicz, Michał Kunc, Anna Gabrych, Aleksandra Fatyga, Ewa Izycka-Swieszewska, Bernarda Kazanowska, Elzbieta Adamkiewicz-Drozynska, Ewa Bien
Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 24 (6) (2019)

Michał Kunc.css-eqlu8i{font-size:small;padding-left:4px;} (Michal Kunc)

Publication Activity (10 Years)

Top Topics

Top Venues

Michał Kunc (Michal Kunc)